Boris Draznin
Concepts (585)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin | 96 | 2013 | 2219 | 4.750 |
Why?
| Diabetes Mellitus | 15 | 2021 | 988 | 3.490 |
Why?
| Hyperglycemia | 10 | 2016 | 335 | 3.350 |
Why?
| Insulin Resistance | 32 | 2013 | 1214 | 2.820 |
Why?
| Phosphatidylinositol 3-Kinases | 17 | 2012 | 354 | 2.300 |
Why?
| Proto-Oncogene Proteins p21(ras) | 23 | 2006 | 238 | 2.220 |
Why?
| Adipocytes | 13 | 2008 | 204 | 1.970 |
Why?
| Receptor, Insulin | 26 | 2003 | 101 | 1.930 |
Why?
| Hypoglycemic Agents | 14 | 2021 | 1081 | 1.910 |
Why?
| Alkyl and Aryl Transferases | 14 | 2003 | 34 | 1.750 |
Why?
| Diabetes Mellitus, Type 2 | 16 | 2021 | 2236 | 1.680 |
Why?
| Blood Glucose | 24 | 2020 | 2008 | 1.630 |
Why?
| Insulin, Long-Acting | 4 | 2020 | 52 | 1.560 |
Why?
| Hyperinsulinism | 11 | 2009 | 108 | 1.370 |
Why?
| Calcium | 21 | 2007 | 1211 | 1.180 |
Why?
| Protein Prenylation | 11 | 2006 | 20 | 1.080 |
Why?
| Muscle, Smooth, Vascular | 8 | 2007 | 459 | 1.070 |
Why?
| Adipose Tissue | 19 | 2007 | 620 | 1.040 |
Why?
| Muscle, Skeletal | 11 | 2012 | 1568 | 0.900 |
Why?
| Signal Transduction | 25 | 2012 | 4809 | 0.900 |
Why?
| Phosphorylation | 31 | 2013 | 1694 | 0.880 |
Why?
| Insulin Receptor Substrate Proteins | 15 | 2013 | 60 | 0.880 |
Why?
| Hospitalization | 5 | 2016 | 1960 | 0.870 |
Why?
| Rats | 69 | 2007 | 5517 | 0.850 |
Why?
| Obesity | 15 | 2013 | 2805 | 0.740 |
Why?
| Insulin Glargine | 4 | 2014 | 75 | 0.730 |
Why?
| Cytosol | 16 | 1994 | 232 | 0.720 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 75 | 0.710 |
Why?
| Monosaccharide Transport Proteins | 9 | 2003 | 46 | 0.710 |
Why?
| Inpatients | 3 | 2013 | 414 | 0.690 |
Why?
| Epidemics | 1 | 2021 | 76 | 0.690 |
Why?
| Animals | 106 | 2013 | 34345 | 0.670 |
Why?
| Glucose | 25 | 2006 | 995 | 0.630 |
Why?
| Proteins | 15 | 2001 | 951 | 0.620 |
Why?
| Myocytes, Smooth Muscle | 3 | 2006 | 246 | 0.610 |
Why?
| Physicians, Primary Care | 1 | 2021 | 246 | 0.590 |
Why?
| Platelet-Derived Growth Factor | 4 | 2003 | 86 | 0.580 |
Why?
| Deoxyglucose | 10 | 2008 | 51 | 0.580 |
Why?
| Dietary Fats | 5 | 2012 | 332 | 0.570 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2020 | 3471 | 0.570 |
Why?
| Endocrinology | 1 | 2018 | 73 | 0.560 |
Why?
| Enzyme Inhibitors | 12 | 2007 | 841 | 0.550 |
Why?
| Adiponectin | 4 | 2009 | 233 | 0.540 |
Why?
| 3T3-L1 Cells | 5 | 2008 | 36 | 0.540 |
Why?
| Enteral Nutrition | 3 | 2013 | 175 | 0.530 |
Why?
| Insulin-Like Growth Factor I | 11 | 2005 | 303 | 0.530 |
Why?
| Phosphoproteins | 10 | 2007 | 320 | 0.520 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 84 | 0.520 |
Why?
| Islets of Langerhans | 17 | 1991 | 745 | 0.510 |
Why?
| Somatostatin | 13 | 2001 | 54 | 0.500 |
Why?
| Protein Kinases | 3 | 2008 | 325 | 0.500 |
Why?
| Academic Medical Centers | 1 | 2018 | 447 | 0.490 |
Why?
| Patient Care Planning | 1 | 2016 | 151 | 0.490 |
Why?
| Farnesyltranstransferase | 11 | 2009 | 21 | 0.490 |
Why?
| Triglycerides | 3 | 2012 | 551 | 0.480 |
Why?
| Insulin, Isophane | 2 | 2013 | 17 | 0.480 |
Why?
| Growth Hormone | 8 | 2007 | 108 | 0.480 |
Why?
| 3T3 Cells | 13 | 2007 | 141 | 0.470 |
Why?
| Humans | 65 | 2021 | 125131 | 0.470 |
Why?
| Phosphates | 3 | 2007 | 170 | 0.460 |
Why?
| Glucocorticoids | 2 | 2016 | 554 | 0.460 |
Why?
| Dietary Carbohydrates | 3 | 2012 | 161 | 0.460 |
Why?
| Rats, Inbred Strains | 26 | 1992 | 414 | 0.460 |
Why?
| Cells, Cultured | 25 | 2008 | 4159 | 0.450 |
Why?
| Guanosine Triphosphate | 12 | 2000 | 94 | 0.440 |
Why?
| Muscle Proteins | 4 | 2012 | 224 | 0.430 |
Why?
| Medically Uninsured | 1 | 2014 | 135 | 0.430 |
Why?
| Liver | 15 | 2009 | 1872 | 0.430 |
Why?
| Kinetics | 24 | 2012 | 1680 | 0.420 |
Why?
| Continuity of Patient Care | 2 | 2019 | 281 | 0.410 |
Why?
| Practice Guidelines as Topic | 2 | 2018 | 1530 | 0.410 |
Why?
| Cystic Fibrosis | 2 | 2012 | 990 | 0.410 |
Why?
| Sirtuin 1 | 1 | 2012 | 31 | 0.410 |
Why?
| Patient Preference | 1 | 2014 | 174 | 0.400 |
Why?
| Biphasic Insulins | 1 | 2011 | 3 | 0.400 |
Why?
| Muscles | 3 | 2004 | 340 | 0.400 |
Why?
| Diabetes Mellitus, Experimental | 5 | 1992 | 216 | 0.390 |
Why?
| Decision Making | 2 | 2018 | 861 | 0.390 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 3 | 2007 | 60 | 0.390 |
Why?
| Patient Care Team | 1 | 2016 | 546 | 0.390 |
Why?
| Insulin Lispro | 1 | 2011 | 35 | 0.390 |
Why?
| Enzyme Activation | 10 | 2008 | 863 | 0.390 |
Why?
| Mice | 28 | 2009 | 15984 | 0.380 |
Why?
| Cell Membrane | 18 | 2003 | 732 | 0.380 |
Why?
| AMP-Activated Protein Kinases | 1 | 2012 | 181 | 0.370 |
Why?
| Atherosclerosis | 4 | 2019 | 360 | 0.370 |
Why?
| Methylprednisolone | 1 | 2011 | 86 | 0.360 |
Why?
| Patient Admission | 1 | 2012 | 198 | 0.360 |
Why?
| Biomarkers | 3 | 2020 | 3736 | 0.360 |
Why?
| Thiazolidinediones | 2 | 2008 | 154 | 0.360 |
Why?
| Phosphoprotein Phosphatases | 4 | 1995 | 71 | 0.350 |
Why?
| Receptors, Cell Surface | 12 | 1986 | 368 | 0.350 |
Why?
| Quality Improvement | 2 | 2018 | 1020 | 0.350 |
Why?
| Hospitals | 2 | 2013 | 654 | 0.350 |
Why?
| Blotting, Western | 9 | 2012 | 1233 | 0.340 |
Why?
| Epidermal Growth Factor | 6 | 1998 | 175 | 0.340 |
Why?
| Dose-Response Relationship, Drug | 9 | 2011 | 2026 | 0.340 |
Why?
| Male | 54 | 2020 | 60792 | 0.340 |
Why?
| Medicaid | 1 | 2014 | 429 | 0.340 |
Why?
| Phosphoric Monoester Hydrolases | 4 | 1994 | 61 | 0.340 |
Why?
| Pituitary Gland, Anterior | 5 | 1988 | 47 | 0.340 |
Why?
| Adaptor Proteins, Signal Transducing | 5 | 2001 | 400 | 0.340 |
Why?
| rhoA GTP-Binding Protein | 4 | 2003 | 81 | 0.330 |
Why?
| DNA-Binding Proteins | 5 | 2004 | 1373 | 0.320 |
Why?
| MAP Kinase Signaling System | 3 | 2006 | 304 | 0.320 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 16 | 0.320 |
Why?
| Oligonucleotides, Antisense | 1 | 2009 | 103 | 0.320 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2001 | 145 | 0.320 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 13 | 0.320 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 299 | 0.310 |
Why?
| Adult | 19 | 2020 | 33167 | 0.310 |
Why?
| Algorithms | 1 | 2016 | 1618 | 0.310 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 175 | 0.310 |
Why?
| Endothelium, Vascular | 2 | 2007 | 919 | 0.300 |
Why?
| Mitochondrial Diseases | 1 | 2008 | 80 | 0.300 |
Why?
| Cyclic AMP | 9 | 1993 | 264 | 0.300 |
Why?
| Transfection | 9 | 2008 | 923 | 0.300 |
Why?
| Leukocytes | 2 | 2006 | 292 | 0.290 |
Why?
| Diabetic Angiopathies | 2 | 2007 | 276 | 0.290 |
Why?
| Pregnancy Proteins | 2 | 2005 | 38 | 0.290 |
Why?
| Androstadienes | 5 | 2008 | 94 | 0.280 |
Why?
| Early Growth Response Protein 1 | 2 | 2006 | 32 | 0.270 |
Why?
| Phosphoserine | 1 | 2006 | 34 | 0.270 |
Why?
| Female | 28 | 2020 | 64889 | 0.270 |
Why?
| src Homology Domains | 2 | 2003 | 35 | 0.270 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 1248 | 0.270 |
Why?
| Fetal Macrosomia | 1 | 2006 | 60 | 0.270 |
Why?
| Organophosphonates | 2 | 1997 | 96 | 0.270 |
Why?
| Fasting | 7 | 2005 | 269 | 0.270 |
Why?
| Cytoplasmic Granules | 6 | 1986 | 102 | 0.270 |
Why?
| Middle Aged | 15 | 2020 | 29112 | 0.260 |
Why?
| Glyburide | 6 | 1988 | 43 | 0.260 |
Why?
| Food Deprivation | 1 | 2006 | 24 | 0.260 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 54 | 0.260 |
Why?
| Physical Conditioning, Animal | 2 | 2006 | 209 | 0.260 |
Why?
| Mitogens | 3 | 2001 | 60 | 0.260 |
Why?
| Fatty Acids | 2 | 2012 | 414 | 0.260 |
Why?
| RNA, Messenger | 8 | 2006 | 2753 | 0.260 |
Why?
| Transcription Factors | 5 | 2004 | 1604 | 0.250 |
Why?
| Transferases | 4 | 1997 | 31 | 0.250 |
Why?
| Diabetes, Gestational | 2 | 2006 | 289 | 0.240 |
Why?
| Adaptor Proteins, Vesicular Transport | 3 | 2001 | 47 | 0.240 |
Why?
| Fetal Blood | 1 | 2006 | 278 | 0.240 |
Why?
| In Vitro Techniques | 15 | 2003 | 1144 | 0.240 |
Why?
| Diet, Reducing | 1 | 2005 | 84 | 0.240 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 2004 | 41 | 0.240 |
Why?
| Diabetes Complications | 2 | 2019 | 231 | 0.240 |
Why?
| Protein Subunits | 4 | 2008 | 220 | 0.240 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 34 | 0.240 |
Why?
| Cell Line | 12 | 2008 | 2806 | 0.220 |
Why?
| ras Proteins | 2 | 2009 | 144 | 0.220 |
Why?
| Protein Kinase C | 3 | 1996 | 304 | 0.220 |
Why?
| Garlic | 1 | 2003 | 3 | 0.220 |
Why?
| Sulfinic Acids | 1 | 2003 | 7 | 0.220 |
Why?
| Cell Nucleus | 3 | 1995 | 593 | 0.210 |
Why?
| Drug Synergism | 5 | 2003 | 344 | 0.210 |
Why?
| Up-Regulation | 1 | 2006 | 895 | 0.210 |
Why?
| Metabolic Syndrome | 3 | 2013 | 399 | 0.200 |
Why?
| Cell Division | 4 | 2009 | 796 | 0.200 |
Why?
| Sodium-Potassium-Exchanging ATPase | 2 | 1992 | 54 | 0.190 |
Why?
| Caloric Restriction | 2 | 2012 | 97 | 0.190 |
Why?
| Plant Extracts | 1 | 2003 | 171 | 0.190 |
Why?
| Growth Substances | 2 | 1998 | 139 | 0.180 |
Why?
| Aged | 7 | 2020 | 20859 | 0.180 |
Why?
| Weight Loss | 1 | 2005 | 677 | 0.180 |
Why?
| Angiotensin II | 1 | 2000 | 109 | 0.180 |
Why?
| Nitrendipine | 7 | 1993 | 13 | 0.180 |
Why?
| Lysophospholipids | 1 | 2000 | 71 | 0.180 |
Why?
| Fetal Diseases | 1 | 2001 | 152 | 0.180 |
Why?
| Oxidative Stress | 1 | 2006 | 1210 | 0.170 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1996 | 43 | 0.170 |
Why?
| Insulin Infusion Systems | 2 | 2012 | 316 | 0.170 |
Why?
| Deoxy Sugars | 2 | 1989 | 2 | 0.170 |
Why?
| Cattle | 6 | 2007 | 1010 | 0.170 |
Why?
| Gene Expression Regulation | 3 | 2012 | 2492 | 0.170 |
Why?
| Drug Prescriptions | 1 | 2021 | 274 | 0.160 |
Why?
| Receptor, IGF Type 1 | 1 | 1998 | 60 | 0.160 |
Why?
| Aging | 5 | 1992 | 1706 | 0.160 |
Why?
| GTP-Binding Proteins | 1 | 1999 | 159 | 0.150 |
Why?
| Serine | 2 | 2008 | 143 | 0.150 |
Why?
| Young Adult | 6 | 2020 | 11384 | 0.150 |
Why?
| Cations | 1 | 1998 | 81 | 0.150 |
Why?
| Fellowships and Scholarships | 1 | 2021 | 270 | 0.150 |
Why?
| Pilot Projects | 2 | 2014 | 1530 | 0.150 |
Why?
| Protein Tyrosine Phosphatases | 3 | 1996 | 149 | 0.150 |
Why?
| Receptors, Somatostatin | 11 | 1986 | 25 | 0.150 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2003 | 307 | 0.140 |
Why?
| Fibroblasts | 6 | 2001 | 859 | 0.140 |
Why?
| Models, Organizational | 1 | 2018 | 151 | 0.140 |
Why?
| Retrospective Studies | 4 | 2016 | 13708 | 0.140 |
Why?
| Time Factors | 7 | 2006 | 6780 | 0.140 |
Why?
| Life Style | 1 | 2019 | 442 | 0.140 |
Why?
| NF-kappa B | 1 | 2000 | 681 | 0.140 |
Why?
| Oncogene Protein v-akt | 2 | 2008 | 26 | 0.140 |
Why?
| Exocytosis | 5 | 1988 | 91 | 0.140 |
Why?
| Hypertension | 3 | 2019 | 1257 | 0.130 |
Why?
| 1-Methyl-3-isobutylxanthine | 6 | 1986 | 25 | 0.130 |
Why?
| Quality of Health Care | 1 | 2021 | 658 | 0.130 |
Why?
| Potassium | 7 | 1992 | 154 | 0.130 |
Why?
| Recombinant Proteins | 5 | 2001 | 1327 | 0.130 |
Why?
| Swine, Miniature | 2 | 2013 | 73 | 0.130 |
Why?
| Calcium-Transporting ATPases | 2 | 1993 | 36 | 0.130 |
Why?
| Cardiovascular Agents | 1 | 2016 | 141 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1008 | 0.130 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 158 | 0.130 |
Why?
| Mice, Obese | 2 | 2009 | 59 | 0.120 |
Why?
| Somatomedins | 5 | 1981 | 29 | 0.120 |
Why?
| Glycogen Synthase | 2 | 1991 | 14 | 0.120 |
Why?
| Placenta Growth Factor | 2 | 2005 | 26 | 0.120 |
Why?
| United States | 5 | 2021 | 13613 | 0.120 |
Why?
| Rats, Sprague-Dawley | 5 | 2006 | 2512 | 0.120 |
Why?
| Treatment Outcome | 3 | 2018 | 9790 | 0.120 |
Why?
| Breast Neoplasms | 2 | 2003 | 2059 | 0.120 |
Why?
| Glucose Transporter Type 4 | 3 | 2003 | 39 | 0.120 |
Why?
| Rats, Zucker | 2 | 2007 | 35 | 0.120 |
Why?
| Thinness | 2 | 2012 | 95 | 0.110 |
Why?
| Fatty Acid Synthases | 2 | 2006 | 30 | 0.110 |
Why?
| Inulin | 1 | 1993 | 6 | 0.110 |
Why?
| Point-of-Care Systems | 1 | 2015 | 161 | 0.110 |
Why?
| Glucose Tolerance Test | 3 | 2009 | 373 | 0.110 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2018 | 551 | 0.110 |
Why?
| Monitoring, Physiologic | 1 | 2015 | 290 | 0.110 |
Why?
| ras Guanine Nucleotide Exchange Factors | 5 | 1996 | 8 | 0.110 |
Why?
| Referral and Consultation | 1 | 2018 | 705 | 0.110 |
Why?
| GRB2 Adaptor Protein | 5 | 2001 | 12 | 0.110 |
Why?
| Guanosine Diphosphate | 4 | 1997 | 21 | 0.100 |
Why?
| Education, Medical | 1 | 1996 | 255 | 0.100 |
Why?
| Mice, Transgenic | 4 | 2007 | 2061 | 0.100 |
Why?
| Insulin Antagonists | 2 | 2008 | 6 | 0.100 |
Why?
| Cricetinae | 3 | 2001 | 276 | 0.100 |
Why?
| Guanine Nucleotide Exchange Factors | 5 | 1996 | 61 | 0.100 |
Why?
| Injections, Subcutaneous | 1 | 2012 | 139 | 0.100 |
Why?
| Prognosis | 1 | 2020 | 3616 | 0.100 |
Why?
| Parenteral Nutrition | 1 | 2013 | 96 | 0.100 |
Why?
| Models, Biological | 4 | 2007 | 1753 | 0.100 |
Why?
| ras GTPase-Activating Proteins | 3 | 1996 | 14 | 0.100 |
Why?
| Transcription, Genetic | 3 | 2012 | 1376 | 0.100 |
Why?
| Phospholipases A | 1 | 1991 | 101 | 0.100 |
Why?
| Health Services Accessibility | 1 | 2018 | 845 | 0.100 |
Why?
| Mice, Inbred C57BL | 4 | 2009 | 5102 | 0.100 |
Why?
| ErbB Receptors | 4 | 1996 | 574 | 0.100 |
Why?
| Flavonoids | 2 | 2004 | 74 | 0.090 |
Why?
| GTPase-Activating Proteins | 3 | 1996 | 74 | 0.090 |
Why?
| Renal Insufficiency | 1 | 2013 | 155 | 0.090 |
Why?
| PPAR gamma | 1 | 2012 | 190 | 0.090 |
Why?
| Chromones | 2 | 2004 | 40 | 0.090 |
Why?
| Membrane Proteins | 2 | 1996 | 1089 | 0.090 |
Why?
| Isoenzymes | 1 | 1991 | 311 | 0.090 |
Why?
| Energy Metabolism | 3 | 2012 | 786 | 0.090 |
Why?
| RNA | 2 | 2009 | 875 | 0.090 |
Why?
| Oncogene Protein p21(ras) | 3 | 1994 | 25 | 0.090 |
Why?
| Luciferases | 2 | 2000 | 154 | 0.090 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 66 | 0.090 |
Why?
| Morpholines | 2 | 2004 | 108 | 0.090 |
Why?
| Reference Values | 5 | 2002 | 818 | 0.090 |
Why?
| Ion Channels | 2 | 1988 | 128 | 0.090 |
Why?
| Genes, Reporter | 2 | 2000 | 274 | 0.090 |
Why?
| Diet | 3 | 2013 | 1178 | 0.090 |
Why?
| Genes | 1 | 1990 | 237 | 0.090 |
Why?
| Critical Illness | 1 | 2015 | 719 | 0.080 |
Why?
| Telemedicine | 1 | 2018 | 716 | 0.080 |
Why?
| Renal Dialysis | 1 | 2013 | 393 | 0.080 |
Why?
| Tyrosine | 2 | 2008 | 243 | 0.080 |
Why?
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.080 |
Why?
| Cyclosporins | 1 | 1988 | 60 | 0.080 |
Why?
| Cell Movement | 2 | 2003 | 913 | 0.080 |
Why?
| Aorta | 1 | 1991 | 417 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2019 | 6936 | 0.080 |
Why?
| Lipid Metabolism | 1 | 2012 | 485 | 0.080 |
Why?
| CHO Cells | 2 | 2001 | 148 | 0.080 |
Why?
| Verapamil | 4 | 1988 | 33 | 0.080 |
Why?
| Biological Transport | 3 | 1998 | 392 | 0.080 |
Why?
| Patient Readmission | 1 | 2014 | 694 | 0.080 |
Why?
| Erectile Dysfunction | 1 | 1988 | 38 | 0.080 |
Why?
| Liver Glycogen | 3 | 1986 | 24 | 0.070 |
Why?
| Gene Knockdown Techniques | 1 | 2008 | 317 | 0.070 |
Why?
| Exercise Tolerance | 1 | 2009 | 245 | 0.070 |
Why?
| Calcium Channels | 1 | 1988 | 158 | 0.070 |
Why?
| Patient Discharge | 1 | 2014 | 857 | 0.070 |
Why?
| PPAR alpha | 1 | 2007 | 56 | 0.070 |
Why?
| Mevalonic Acid | 2 | 1997 | 7 | 0.070 |
Why?
| Parathyroid Hormone | 3 | 1993 | 99 | 0.070 |
Why?
| Lovastatin | 3 | 1996 | 34 | 0.070 |
Why?
| Fenofibrate | 1 | 2007 | 24 | 0.070 |
Why?
| Transcription Factor Pit-1 | 1 | 2007 | 24 | 0.070 |
Why?
| Sodium-Phosphate Cotransporter Proteins | 1 | 2007 | 10 | 0.070 |
Why?
| Farnesol | 2 | 1997 | 5 | 0.070 |
Why?
| Swine | 3 | 2013 | 786 | 0.070 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 198 | 0.070 |
Why?
| Hypoglycemia | 1 | 2011 | 413 | 0.070 |
Why?
| Eating | 1 | 1990 | 388 | 0.070 |
Why?
| Recombinant Fusion Proteins | 2 | 2001 | 658 | 0.070 |
Why?
| Genetic Therapy | 1 | 2008 | 267 | 0.070 |
Why?
| Prospective Studies | 2 | 2012 | 6818 | 0.070 |
Why?
| Gene Expression | 1 | 2012 | 1528 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 94 | 0.070 |
Why?
| Prostheses and Implants | 1 | 1988 | 161 | 0.070 |
Why?
| Proto-Oncogene Proteins c-raf | 2 | 1996 | 46 | 0.070 |
Why?
| Cell Fusion | 1 | 1986 | 52 | 0.070 |
Why?
| Adenosine Triphosphate | 3 | 1993 | 459 | 0.070 |
Why?
| Bucladesine | 3 | 1992 | 24 | 0.070 |
Why?
| Mice, Knockout | 2 | 2005 | 2736 | 0.070 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2006 | 16 | 0.070 |
Why?
| Organophosphorus Compounds | 2 | 1997 | 79 | 0.070 |
Why?
| RNA, Small Interfering | 1 | 2008 | 584 | 0.070 |
Why?
| Microscopy, Electron | 4 | 1989 | 420 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 1324 | 0.070 |
Why?
| Macromolecular Substances | 3 | 1996 | 207 | 0.070 |
Why?
| Coated Pits, Cell-Membrane | 1 | 1985 | 4 | 0.070 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2008 | 379 | 0.060 |
Why?
| Macaca mulatta | 1 | 2006 | 149 | 0.060 |
Why?
| Heart | 1 | 2009 | 668 | 0.060 |
Why?
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 3 | 2001 | 10 | 0.060 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2001 | 10 | 0.060 |
Why?
| Activating Transcription Factor 1 | 2 | 1995 | 9 | 0.060 |
Why?
| Interleukin-1 | 1 | 1989 | 984 | 0.060 |
Why?
| Peptides | 2 | 1981 | 884 | 0.060 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 292 | 0.060 |
Why?
| Theophylline | 1 | 1985 | 61 | 0.060 |
Why?
| Basal Metabolism | 1 | 2005 | 51 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 178 | 0.060 |
Why?
| Body Weight | 6 | 2002 | 959 | 0.060 |
Why?
| Hemodynamics | 1 | 2009 | 1093 | 0.060 |
Why?
| Endosomes | 1 | 1985 | 128 | 0.060 |
Why?
| Bacterial Proteins | 1 | 1990 | 777 | 0.060 |
Why?
| Risk | 1 | 2007 | 896 | 0.060 |
Why?
| Retroviridae Proteins, Oncogenic | 1 | 2003 | 12 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 3 | 1993 | 413 | 0.060 |
Why?
| Blotting, Northern | 3 | 1995 | 206 | 0.060 |
Why?
| Colorado | 1 | 2014 | 4471 | 0.060 |
Why?
| Pregnancy | 3 | 2006 | 5922 | 0.060 |
Why?
| Arachidonic Acids | 3 | 1988 | 58 | 0.060 |
Why?
| Phosphorus Radioisotopes | 2 | 1993 | 30 | 0.050 |
Why?
| Breast | 1 | 2003 | 153 | 0.050 |
Why?
| Energy Intake | 2 | 2005 | 463 | 0.050 |
Why?
| Proto-Oncogene Proteins | 2 | 1996 | 656 | 0.050 |
Why?
| Hypothyroidism | 2 | 1980 | 68 | 0.050 |
Why?
| Placental Hormones | 1 | 2002 | 5 | 0.050 |
Why?
| Streptozocin | 2 | 1992 | 23 | 0.050 |
Why?
| Disease Models, Animal | 4 | 2013 | 3823 | 0.050 |
Why?
| Cell Differentiation | 2 | 2001 | 1778 | 0.050 |
Why?
| Receptors, Progesterone | 1 | 2003 | 327 | 0.050 |
Why?
| Carrier Proteins | 3 | 1980 | 743 | 0.050 |
Why?
| Fetal Weight | 1 | 2001 | 52 | 0.050 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 836 | 0.050 |
Why?
| Starvation | 1 | 1981 | 24 | 0.050 |
Why?
| Colforsin | 3 | 1991 | 62 | 0.050 |
Why?
| Calmodulin | 3 | 1986 | 76 | 0.050 |
Why?
| Receptors, Estrogen | 1 | 2003 | 392 | 0.050 |
Why?
| Nitric Oxide Synthase | 1 | 2001 | 226 | 0.050 |
Why?
| Transcriptional Activation | 2 | 2000 | 363 | 0.050 |
Why?
| Serum Response Factor | 1 | 2000 | 30 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2001 | 391 | 0.040 |
Why?
| Maternal-Fetal Exchange | 1 | 2001 | 160 | 0.040 |
Why?
| Glucosamine | 1 | 2000 | 14 | 0.040 |
Why?
| Response Elements | 1 | 2000 | 87 | 0.040 |
Why?
| Lysosomes | 1 | 1981 | 136 | 0.040 |
Why?
| Glycation End Products, Advanced | 1 | 2000 | 72 | 0.040 |
Why?
| Adenoviridae | 1 | 2001 | 196 | 0.040 |
Why?
| Hypopituitarism | 1 | 1980 | 16 | 0.040 |
Why?
| Disease Progression | 1 | 2007 | 2577 | 0.040 |
Why?
| Son of Sevenless Proteins | 2 | 1996 | 5 | 0.040 |
Why?
| Leptin | 1 | 2001 | 233 | 0.040 |
Why?
| Fura-2 | 2 | 1991 | 22 | 0.040 |
Why?
| Mice, Mutant Strains | 1 | 2000 | 289 | 0.040 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 199 | 0.040 |
Why?
| Arachidonic Acid | 3 | 1988 | 120 | 0.040 |
Why?
| Muscle Denervation | 1 | 1999 | 9 | 0.040 |
Why?
| Endocrinologists | 1 | 2019 | 12 | 0.040 |
Why?
| Aurothioglucose | 1 | 1999 | 6 | 0.040 |
Why?
| Clenbuterol | 1 | 1999 | 3 | 0.040 |
Why?
| rab3 GTP-Binding Proteins | 1 | 1999 | 2 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 1999 | 9 | 0.040 |
Why?
| Body Composition | 3 | 2009 | 679 | 0.040 |
Why?
| Ionomycin | 2 | 1989 | 25 | 0.040 |
Why?
| Dogs | 1 | 2000 | 394 | 0.040 |
Why?
| Sheep | 1 | 2001 | 768 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2000 | 902 | 0.040 |
Why?
| Vascular Endothelial Growth Factors | 1 | 1998 | 68 | 0.040 |
Why?
| Fatty Acids, Nonesterified | 3 | 2009 | 174 | 0.040 |
Why?
| Endothelial Growth Factors | 1 | 1998 | 55 | 0.040 |
Why?
| Lymphokines | 1 | 1998 | 122 | 0.040 |
Why?
| Diabetic Neuropathies | 1 | 2019 | 79 | 0.040 |
Why?
| Hyperlipidemias | 1 | 2019 | 144 | 0.040 |
Why?
| Protein Phosphatase 2 | 2 | 1995 | 41 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2000 | 420 | 0.040 |
Why?
| Binding Sites | 2 | 1996 | 1248 | 0.040 |
Why?
| Ethanol | 1 | 1983 | 735 | 0.040 |
Why?
| Prosencephalon | 2 | 1994 | 51 | 0.040 |
Why?
| Half-Life | 1 | 1997 | 150 | 0.040 |
Why?
| Rats, Wistar | 1 | 1998 | 409 | 0.040 |
Why?
| Magnesium | 1 | 1998 | 159 | 0.040 |
Why?
| Dinitrophenols | 3 | 1982 | 7 | 0.040 |
Why?
| Growth Hormone-Releasing Hormone | 2 | 1988 | 27 | 0.040 |
Why?
| Body Mass Index | 1 | 2005 | 2174 | 0.040 |
Why?
| Physician's Role | 1 | 2019 | 211 | 0.040 |
Why?
| Diabetic Retinopathy | 1 | 2019 | 162 | 0.040 |
Why?
| Fetus | 1 | 2001 | 713 | 0.040 |
Why?
| Phenytoin | 1 | 1977 | 15 | 0.040 |
Why?
| Accidental Falls | 1 | 2019 | 160 | 0.030 |
Why?
| Oxygen Consumption | 2 | 2009 | 620 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1996 | 10 | 0.030 |
Why?
| Protein Phosphatase 1 | 2 | 1993 | 32 | 0.030 |
Why?
| Immunosorbent Techniques | 1 | 1996 | 18 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1996 | 21 | 0.030 |
Why?
| Second Messenger Systems | 1 | 1996 | 34 | 0.030 |
Why?
| Neurons | 2 | 1994 | 1365 | 0.030 |
Why?
| Nuclear Proteins | 1 | 2000 | 614 | 0.030 |
Why?
| Prediabetic State | 1 | 2019 | 241 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 119 | 0.030 |
Why?
| Diabetic Nephropathies | 1 | 2019 | 293 | 0.030 |
Why?
| Infant, Newborn | 1 | 2006 | 5456 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 1998 | 537 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1986 | 244 | 0.030 |
Why?
| Genes, Immediate-Early | 1 | 1995 | 18 | 0.030 |
Why?
| Immunoblotting | 1 | 1996 | 313 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2340 | 0.030 |
Why?
| Off-Label Use | 1 | 2015 | 56 | 0.030 |
Why?
| Immediate-Early Proteins | 1 | 1995 | 56 | 0.030 |
Why?
| Phenotype | 1 | 2003 | 3153 | 0.030 |
Why?
| Research Support as Topic | 1 | 1996 | 123 | 0.030 |
Why?
| Trypsin | 2 | 1993 | 72 | 0.030 |
Why?
| Glycogen | 1 | 1995 | 58 | 0.030 |
Why?
| Disease Management | 1 | 2019 | 599 | 0.030 |
Why?
| Sequence Deletion | 1 | 1995 | 178 | 0.030 |
Why?
| Peptide Mapping | 1 | 1994 | 64 | 0.030 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1994 | 12 | 0.030 |
Why?
| DNA | 2 | 1998 | 1406 | 0.030 |
Why?
| ras-GRF1 | 1 | 1993 | 2 | 0.030 |
Why?
| Receptor, ErbB-2 | 1 | 1996 | 327 | 0.030 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1996 | 410 | 0.030 |
Why?
| Mutation | 1 | 2004 | 3520 | 0.030 |
Why?
| Intracellular Membranes | 2 | 1985 | 78 | 0.030 |
Why?
| Health Services Needs and Demand | 1 | 2015 | 272 | 0.030 |
Why?
| Chloroquine | 2 | 1986 | 63 | 0.030 |
Why?
| Thapsigargin | 1 | 1993 | 18 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 1993 | 47 | 0.030 |
Why?
| Thionucleotides | 1 | 1993 | 34 | 0.030 |
Why?
| Cell Cycle | 1 | 1996 | 578 | 0.030 |
Why?
| Terpenes | 1 | 1993 | 23 | 0.030 |
Why?
| Consensus | 1 | 2015 | 577 | 0.030 |
Why?
| Phenols | 1 | 1993 | 87 | 0.030 |
Why?
| Hormones | 2 | 1984 | 136 | 0.030 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 612 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 369 | 0.030 |
Why?
| Blood Pressure | 2 | 2009 | 1735 | 0.030 |
Why?
| Research | 1 | 1996 | 440 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 1996 | 2098 | 0.030 |
Why?
| Phosphorylase a | 1 | 1992 | 1 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1996 | 420 | 0.030 |
Why?
| Okadaic Acid | 1 | 1991 | 12 | 0.030 |
Why?
| Mesocricetus | 1 | 1991 | 33 | 0.030 |
Why?
| Ethers, Cyclic | 1 | 1991 | 8 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2012 | 198 | 0.020 |
Why?
| Peptide Fragments | 1 | 1996 | 713 | 0.020 |
Why?
| Phospholipases A2 | 1 | 1991 | 76 | 0.020 |
Why?
| Cadaverine | 2 | 1982 | 2 | 0.020 |
Why?
| Vanadates | 1 | 1991 | 29 | 0.020 |
Why?
| Densitometry | 1 | 1991 | 32 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1992 | 158 | 0.020 |
Why?
| Calorimetry | 1 | 2012 | 59 | 0.020 |
Why?
| Mass Screening | 1 | 2019 | 1119 | 0.020 |
Why?
| Wheat Germ Agglutinins | 1 | 1991 | 3 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 1991 | 143 | 0.020 |
Why?
| Dietary Proteins | 1 | 2012 | 134 | 0.020 |
Why?
| Arteries | 1 | 2013 | 257 | 0.020 |
Why?
| Sodium | 1 | 1992 | 211 | 0.020 |
Why?
| Sodium Fluoride | 2 | 1981 | 17 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 340 | 0.020 |
Why?
| Membrane Potentials | 1 | 1991 | 262 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 17 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 64 | 0.020 |
Why?
| Food | 1 | 1992 | 165 | 0.020 |
Why?
| Japan | 1 | 1990 | 105 | 0.020 |
Why?
| Vasodilation | 1 | 2013 | 462 | 0.020 |
Why?
| Secretory Rate | 2 | 1987 | 17 | 0.020 |
Why?
| Homozygote | 1 | 1990 | 195 | 0.020 |
Why?
| Sphingosine | 1 | 1989 | 37 | 0.020 |
Why?
| Nonsuppressible Insulin-Like Activity | 2 | 1979 | 2 | 0.020 |
Why?
| Body Fat Distribution | 1 | 2009 | 48 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 2007 | 1042 | 0.020 |
Why?
| Plethysmography | 1 | 2009 | 126 | 0.020 |
Why?
| Trifluoperazine | 2 | 1987 | 4 | 0.020 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 112 | 0.020 |
Why?
| Cross-Sectional Studies | 2 | 2009 | 4854 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2012 | 943 | 0.020 |
Why?
| Freeze Fracturing | 1 | 1988 | 8 | 0.020 |
Why?
| Hydrostatic Pressure | 1 | 1988 | 21 | 0.020 |
Why?
| Puberty | 1 | 2009 | 148 | 0.020 |
Why?
| Freezing | 1 | 1988 | 86 | 0.020 |
Why?
| Ethers | 1 | 1987 | 17 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2009 | 341 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2009 | 401 | 0.020 |
Why?
| Egtazic Acid | 1 | 1987 | 45 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 437 | 0.020 |
Why?
| Benzofurans | 1 | 1987 | 24 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2009 | 381 | 0.020 |
Why?
| Linear Models | 1 | 2009 | 870 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 1987 | 172 | 0.020 |
Why?
| Exercise Test | 1 | 2009 | 585 | 0.020 |
Why?
| Adolescent | 4 | 2009 | 19411 | 0.020 |
Why?
| Echocardiography | 1 | 2009 | 609 | 0.020 |
Why?
| Digitonin | 1 | 1986 | 5 | 0.020 |
Why?
| Culture Techniques | 1 | 1986 | 84 | 0.020 |
Why?
| Glyceraldehyde | 1 | 1985 | 5 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 2154 | 0.020 |
Why?
| Pronase | 1 | 1985 | 5 | 0.020 |
Why?
| Sonication | 1 | 1985 | 10 | 0.020 |
Why?
| DNA Primers | 1 | 2007 | 545 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1986 | 90 | 0.020 |
Why?
| Lipids | 1 | 2009 | 629 | 0.020 |
Why?
| Heart Rate | 1 | 2009 | 758 | 0.020 |
Why?
| Feedback | 1 | 1986 | 157 | 0.020 |
Why?
| Interleukin-6 | 1 | 2009 | 710 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 1987 | 319 | 0.020 |
Why?
| Golgi Apparatus | 1 | 1985 | 96 | 0.020 |
Why?
| Urea | 1 | 1985 | 77 | 0.020 |
Why?
| Stimulation, Chemical | 1 | 1985 | 64 | 0.020 |
Why?
| Organoids | 1 | 1986 | 81 | 0.020 |
Why?
| Peptide Hydrolases | 1 | 1986 | 110 | 0.020 |
Why?
| Binding, Competitive | 1 | 1985 | 209 | 0.020 |
Why?
| Homeostasis | 1 | 1988 | 605 | 0.020 |
Why?
| Biopsy | 1 | 1988 | 1093 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 1904 | 0.020 |
Why?
| Tissue Distribution | 1 | 1985 | 342 | 0.020 |
Why?
| Gold | 1 | 1985 | 108 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 689 | 0.010 |
Why?
| Chick Embryo | 2 | 1994 | 133 | 0.010 |
Why?
| Thyroxine | 2 | 1981 | 63 | 0.010 |
Why?
| Perfusion | 2 | 1981 | 170 | 0.010 |
Why?
| Endocytosis | 1 | 1984 | 157 | 0.010 |
Why?
| 2,4-Dinitrophenol | 1 | 1982 | 10 | 0.010 |
Why?
| Cycloheximide | 1 | 1982 | 60 | 0.010 |
Why?
| Colchicine | 1 | 1982 | 27 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1982 | 74 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2002 | 22 | 0.010 |
Why?
| Deuterium | 1 | 1982 | 80 | 0.010 |
Why?
| Case-Control Studies | 1 | 2009 | 3326 | 0.010 |
Why?
| Receptors, Somatomedin | 1 | 1981 | 3 | 0.010 |
Why?
| Nutrition Disorders | 1 | 1981 | 23 | 0.010 |
Why?
| Purine Nucleotides | 1 | 1981 | 12 | 0.010 |
Why?
| Radioisotopes | 1 | 1981 | 35 | 0.010 |
Why?
| Intracellular Fluid | 1 | 1981 | 27 | 0.010 |
Why?
| Biotransformation | 1 | 1981 | 53 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 1980 | 52 | 0.010 |
Why?
| Adenosine Diphosphate | 1 | 1980 | 90 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1981 | 562 | 0.010 |
Why?
| Follow-Up Studies | 1 | 1988 | 4824 | 0.010 |
Why?
| Statistics as Topic | 1 | 1980 | 319 | 0.010 |
Why?
| Growth Disorders | 1 | 1979 | 87 | 0.010 |
Why?
| Inflammation | 1 | 2009 | 2612 | 0.010 |
Why?
| 11-Hydroxycorticosteroids | 1 | 1977 | 1 | 0.010 |
Why?
| Phosphotyrosine | 1 | 1996 | 37 | 0.010 |
Why?
| Child | 2 | 2009 | 20014 | 0.010 |
Why?
| Kidney Failure, Chronic | 1 | 1981 | 523 | 0.010 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1995 | 34 | 0.010 |
Why?
| Genes, fos | 1 | 1995 | 37 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1996 | 533 | 0.010 |
Why?
| Neurites | 1 | 1994 | 43 | 0.010 |
Why?
| Protein Binding | 1 | 1980 | 2014 | 0.010 |
Why?
| Microinjections | 1 | 1994 | 84 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1994 | 199 | 0.010 |
Why?
| Antibodies | 1 | 1994 | 396 | 0.010 |
Why?
| Cell Survival | 1 | 1994 | 1081 | 0.010 |
Why?
| Base Sequence | 1 | 1995 | 2207 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1995 | 2926 | 0.010 |
Why?
| Hydroxymercuribenzoates | 1 | 1987 | 1 | 0.000 |
Why?
| Dantrolene | 1 | 1987 | 6 | 0.000 |
Why?
| Oleic Acids | 1 | 1987 | 16 | 0.000 |
Why?
| Oleic Acid | 1 | 1987 | 36 | 0.000 |
Why?
| Lipoxygenase Inhibitors | 1 | 1987 | 39 | 0.000 |
Why?
| Child, Preschool | 1 | 1980 | 9938 | 0.000 |
Why?
| Membrane Fluidity | 1 | 1984 | 13 | 0.000 |
Why?
| Diterpenes | 1 | 1984 | 34 | 0.000 |
Why?
| Glucagon | 1 | 1984 | 98 | 0.000 |
Why?
| Membrane Lipids | 1 | 1984 | 90 | 0.000 |
Why?
| Adenine Nucleotides | 1 | 1982 | 20 | 0.000 |
Why?
| Phospholipids | 1 | 1984 | 210 | 0.000 |
Why?
| Adenosine Triphosphatases | 1 | 1982 | 162 | 0.000 |
Why?
| Nephrectomy | 1 | 1981 | 163 | 0.000 |
Why?
| Propylthiouracil | 1 | 1979 | 2 | 0.000 |
Why?
| Hypophysectomy | 1 | 1979 | 15 | 0.000 |
Why?
| Puromycin | 1 | 1979 | 10 | 0.000 |
Why?
| Radioligand Assay | 1 | 1979 | 48 | 0.000 |
Why?
| Kidney | 1 | 1981 | 1379 | 0.000 |
Why?
|
|
Draznin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|